17
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Alteration in ocular function induced by phenylethylamine analogs of dopamine

, &
Pages 851-859 | Received 16 Jan 1984, Accepted 20 Mar 1984, Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Edward L. McNellis & Larry P. Bausher. (1991) Stimulatory and inhibitory cyclic AMP responses in rabbit ciliary processes after cervical ganglionectomy. Current Eye Research 10:5, pages 399-407.
Read now
Brooks H. Rohde & George C.Y. Chiou. (1989) Characterization of unique ADTN-catecholamine binding sites in the iris root-ciliary body of rabbits. Current Eye Research 8:12, pages 1225-1231.
Read now
P. P. Elena, P. Denis, M. Kosina-Boix & P. Lapalus. (1989) Dopamine receptors in rabbit and rat eye: characterization and localization of DA1 and DA2 binding sites. Current Eye Research 8:1, pages 75-83.
Read now
James A. Burke & David E. Potter. (1987) Aporphine derivatives affect ocular function in diverse ways. Current Eye Research 6:10, pages 1227-1236.
Read now
Craig E. Crosson, James A. Burke, Ming-Fai Chan & David E. Potter. (1987) Ocular Effects of a N,N-Disubstituted 5-OH Aminotetralin (N-0437): Evidence for a Dual Mechanism of Action. Current Eye Research 6:11, pages 1319-1326.
Read now
J. A. Burke & D. E. Potter. (1986) Ocular effects of a relatively selective α2 agonist (UK-14, 304-18) in cats, rabbits and monkeys. Current Eye Research 5:9, pages 665-676.
Read now
G. W. De Vries, A. Mobasser & L. A. Wheeler. (1986) Stimulation of endogenous cyclic AMP levels in ciliary body by SK&F 82526, a novel dopamine receptor agonist. Current Eye Research 5:6, pages 449-456.
Read now

Articles from other publishers (16)

Nicola Pescosolido, Francesco Parisi, Paola Russo, Giuseppe Buomprisco & Marcella Nebbioso. (2013) Role of Dopaminergic Receptors in Glaucomatous Disease Modulation. BioMed Research International 2013, pages 1-5.
Crossref
Jeffrey W. KielHerbert A. Reitsamer. (2007) Paradoxical Effect of Phentolamine on Aqueous Flow in The Rabbit. Journal of Ocular Pharmacology and Therapeutics 23:1, pages 21-26.
Crossref
Vinod Kumar Gupta. (2005) Motion sickness is linked to nystagmus-related trigeminal brain stem input: a new hypothesis. Medical Hypotheses 64:6, pages 1177-1181.
Crossref
JAY W. MCLAREN, LORI A. BACHMAN & RICHARD F. BRUBAKER. (1999) Comparison of Effects of Topical Ibopamine and Epinephrine on the Circadian Rhythm of Intraocular Pressure of the Rabbit Eye as Measured by Telemetry. Journal of Ocular Pharmacology and Therapeutics 15:2, pages 107-116.
Crossref
David E. Potter. (1995) Do dopamine and dopamine receptors have roles in modulating function in the anterior segment?: The evidence. Progress in Retinal and Eye Research 15:1, pages 103-111.
Crossref
David E. Potter, Miller J. Ogidigben & Ashley R. Heath. (1993) Ocular actions of an octahydrobenzo[f]quinoline: Ha117. European Journal of Pharmacology 236:1, pages 61-68.
Crossref
M. Virno, A. Gazzaniga, L. Taverniti, J. Pecori Giraldi & F. De Gregorio. (1992) Dopamine, dopaminergic drugs and ocular hypertension. International Ophthalmology 16:4-5, pages 349-353.
Crossref
T.K. Gerding, B.F.H. Drenth, R.A. de Zeeuw, A.S. Horn, J.L. van Delft & J.A. Oosterhuis. (1990) Ocular and systemic disposition of the dopamine agonist N-0437 in monkeys after ocular administration. Experimental Eye Research 51:1, pages 11-14.
Crossref
D. E. Potter, J. A. Burke & M. J. Ogidigben. (2008) Ocular inhibitory effects of the dopamine DA 2 agonist (Ha‐118) in cats and rabbits . Journal of Autonomic Pharmacology 10:3, pages 153-162.
Crossref
DAVID E. POTTER, CRAIG E. CROSSON, ASHLEY R. HEATH & MILLER J. OGIDIGBEN. (1990) Alpha 2 and DA 2 Agonists as Antiglaucoma Agents: Comparative Pharmacology and Clinical Potential . Journal of Ocular Pharmacology and Therapeutics 6:3, pages 251-257.
Crossref
GEORGE C.Y. CHIOU, BYRON H.P. LI & FAYE Y. CHIOU. (1989) Effects of Dopamine Antagonists Injected Through Vortex Veins on Intraocular Pressure. Journal of Ocular Pharmacology and Therapeutics 5:4, pages 281-291.
Crossref
Michael F. Sugrue. (1989) The pharmacology of antiglaucoma drugs. Pharmacology & Therapeutics 43:1, pages 91-138.
Crossref
DAVID E. POTTER & JAMES A. BURKE. (1988) LY141865: A Relatively Selective DA 2 Agonist with Complex Ocular Activity . Journal of Ocular Pharmacology and Therapeutics 4:1, pages 19-28.
Crossref
Marc J. Siegel, Ping-Yu Lee, Steven M. Podos & Thomas W. Mittag. (1987) Effect of topical pergolide on aqueous dynamics in normal and glaucomatous monkeys. Experimental Eye Research 44:2, pages 227-233.
Crossref
DAVID E. POTTER & JAMES A. BURKE. (1985) Does B-HT 920 Lower Intraocular Pressure in Cats by Interacting with α 2 - and/or DA 2 Adrenoceptors? . Journal of Ocular Pharmacology and Therapeutics 1:1, pages 29-45.
Crossref
Michael F. Sugrue & Robert L. Smith. 1985. 83 91 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.